Mini-MBA: Translation of Science into BusinessCertificate of the Danube-University Krems
|
|
Rapid advances in biological science present tremendous opportunities for the development of biotech and modern pharmaceutical industry. Yet how to capture those opportunities and become business leaders in this emerging industry is a challenge to many professionals who have been trained either in science alone or business only.
This course program targeting on the multidiscipline need of the bio-business, will draw on a rich experience of leaders in this industry and offer insight on how to translate scientific excellence through a chain of processes into successful business. The course program encompasses most of the functional areas in today’s bio-industry and will enable the participants to understand the fundamentals on how to capitalize on scientific breakthroughs, exploit growth and business opportunities and advance products from laboratory into the market place. Through this transformational learning experience, you will be prepared to identify and seize a world of opportunities in the biotech and pharmaceutical industry.
This course program targeting on the multidiscipline need of the bio-business, will draw on a rich experience of leaders in this industry and offer insight on how to translate scientific excellence through a chain of processes into successful business. The course program encompasses most of the functional areas in today’s bio-industry and will enable the participants to understand the fundamentals on how to capitalize on scientific breakthroughs, exploit growth and business opportunities and advance products from laboratory into the market place. Through this transformational learning experience, you will be prepared to identify and seize a world of opportunities in the biotech and pharmaceutical industry.
| Zielgruppe | Future Bio-business managers |
| Zulassungsvoraussetzungen | The course program is directed to people with an academic degree in natural science or medicine (university or university of applied sciences; Mag., PhD, Post-doc, Bachelor). |
| Vortragende |
Hon. Prof. (FH) Dr. Katherine Cohen, CEO, Hookipa Biotech. Hon. Prof. (FH) Dr. Uwe Schlokat, BioPharmaceuticals Baxter BioScience Mag. Elgar Schnegg, MBA, CEO Biocrates, Austria DI Dr. Karl Wagner, Procon management consulting Dr. Johann Schlögl, Fresenius Kabi Graz Prof. (FH) Dr. Bertram Ober, ViruSure Forschungs- und Entwicklungs GMBH Dr. Salma Michor, Michor Consulting, Austria |
| Methode(n) | Course, Seminar |
| Sprache | English |
| Termin | Sept 17 - Sept 21, 2012 |
| Abschluss | Certificate of the Danube-University Krems |
| Dauer | 1 week 9:00-18:00 |
| Teilnahmegebühr | EUR 1.700,-- |
| Veranstaltungsort | Danube University Krems |
| Veranstalter |
Zentrum für Biomedizinische Technologie Department für Gesundheitswissenschaften und Biomedizin |
| Information und Anmeldung |
Katrin Berger Telefon: +43 (0)2732 893-2607, Fax: +43 (0)2732 893-4600 E-Mail: katrin.berger@donau-uni.ac.at |